Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ICMR

Resistance to high-end antibiotics is growing: ICMR

NEW DELHI: A survey carried out by the Indian Council of Medical Research (ICMR) to determine the trend in antibiotic resistance across the country has shown that Acinetobacter baumannii, a gram-negative bacteria known to cause infection in the blood, urinary tract and lungs among others, is resistant to high-end antibiotics.

The Times of India

38% of superbug-infected ICU patients die in 14 days: Study

MUMBAI: Results of the first-ever, year-long surveillance of hospital-acquired infections (HAIs) in 120 ICUs across the country reveals a grim picture of superbugs scoring over medicines.

The Times of India

ICMR starts new initiative in northeast

This latest initiative is part of the 2020 project

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

ICMR releases STW on its website, mobile app

NEW DELHI

The Hindu

Morning Digest | Spectrum bids touch ₹1.49 lakh crore on Day 2 of auction; ICMR invites bids to develop vaccine for monkeypox virus, and more

A select list of stories to read before you start your day

The Hindu

ICMR invites bids to develop vaccine for monkeypox virus

It has isolated virus strain for the first time in the country

The Hindu

ICMR releases guidelines for 54 common illnesses across 11 specialities for use by physicians

The volume III of the 'Standard Treatment Workflows' seeks to address problems associated with irrational use of medicines, over and under diagnosis and poor referral practices, among others.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

COVID-19 triggered stigma, discrimination may keep testing rate low: study

‘Education and need for psychosocial intervention to deal with the negative impact of the stigma on individuals and families affected by COVID-19 continues to be vital,’ says Dr. Padmapriyadarsini

The Hindu

Bhopal: Testing of sickle cell patients to be completed in 6 months

BHOPAL: Governor Mangubhai Patel, chief minister Shivraj Singh Chouhan and Union Health Minister Mansukh Mandaviya took part in a workshop organised on holistic management of sickle cell disease at Indian Institute of Information Technology Designing and Manufacturing in Jabalpur on World Sickle Cell Anemia Awareness Day on Sunday. The workshop…

The Times of India

U.S. to fund 3 Indian research institutions

It announces $122 million to address challenges posed by infectious diseases

The Hindu

COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study

New Delhi The administration of Covaxin as a booster dose enhances vaccine effectiveness against COV

The Hindu

ICMR issues country’s first pre-travel guidelines for children and adolescents with Type-1 diabetes

India has the highest number of incident and prevalent cases of Type-1 diabetes in the world as per recent estimates from the International Diabetes Federation.

The Hindu

Health: Over 95,000 children below 14 suffer from type-1 diabetes in India, says ICMR

Prof (Dr) Balram Bhargava, Director General of ICMR released guidelines for management of type 1 diabetes providing advice on care of diabetes in children, adolescents and adults. Read further on Dynamite News:

Dynamite News

TAC recommends testing of all household and primary contacts of positive cases

The State has since January been following ICMR’s purposive testing strategy

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

ICMR urged to upgrade virology institute in State capital

Steps to strengthen surveillance, resistance against Nipah

The Hindu

Karnataka to increase daily COVID tests to up to 30,000

The target is being increased from the present 10,000 tests per day

The Hindu

Explained | Why India administers ‘precaution dose’ of COVID-19 vaccine, and not ‘booster dose’

As India gears up to administer ‘precaution doses’ of COVID-19 vaccine to eligible population above 18 years from Sunday, the debate over ‘booster’ vs ‘precaution’ doses has arisen.

The Hindu

Lok Sabha updates March 25, 2022

House passes Finance Bill 2022.

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

Omicron can resist Covaxin better: NIV data

PUNE: A study carried out to assess Omicron's immune-escape ability has found that it's better at resisting Covaxin than the original SARS-CoV-2 B.1 (Wuhan) variant, and the Beta and Delta variants. The research was carried out by experts from the Pune-based ICMR-National Institute of Virology (NIV).

The Times of India

Mixing Covishield, Covaxin doses gives better immunity, says ICMR study

PUNE: A study by the Indian Council of Medical Research (ICMR) has found that mixing the two lead Covid-19 vaccines — Covishield and Covaxin — produced a better immune response than a same-dose schedule.

The Hindu

Coronavirus live | 92% of COVID-19 deaths in 2022 have been among unvaccinated: ICMR

The cumulative COVID-19 vaccine doses administered in the country crossed 178.26 crore on Thursday, the Union Health Ministry said

The Hindu

92% of COVID-19 deaths in 2022 have been among unvaccinated: ICMR

ICMR chief Balram Bhargava urged students coming from Ukraine to get vaccinated immediately if they had not already done so.

The Times of India

Delhi reports 360 Covid cases, 4 fatalities; positivity rate drops below 1 pc

NEW DELHI: Delhi on Monday reported 360 coronavirus cases and four fatalities, while the positivity rate dropped below one per cent for the first time since December 28 last year, according to data shared by the health department. Out of these 360 cases, 86 pertain to earlier weeks that were…

The Hindu

National Science Week at ICMR-NIN from Feb. 22

ICMR-NIN to organise displays, posters and live demonstrations for students and common public

The Hindu

ICMR got ₹171.74 crore in royalty from Covaxin sale, Rajya Sabha told

The Council has spent around ₹35 crore in research and development of the vaccine, says Health Ministry

1 2 3 4 5

People

Shivraj Singh Chouhan

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Union Health Ministry

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.